This inventor holds 3 USPTO granted patents and 8 published patent applications and 6 EPO patents. Top assignee: Acandis Gmbh. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: Michael Büchert: Innovator in Medical Catheter Technology
Introduction
Michael Büchert is a notable inventor based in Bretten, Germany. He has made significant contributions to the field of medical technology, particularly in the development of catheters for hypothermic treatment. His innovative approach has led to advancements that enhance patient care and treatment efficacy.
Latest Patents
Büchert holds a patent for a medical catheter designed specifically for hypothermic treatment. This catheter features a catheter tube with at least one through-channel and two temperature control channels. It includes a heat exchange element, such as an expandable balloon, located in the distal portion of the catheter tube. This design allows for the formation of a temperature control circuit, which is crucial for effective hypothermic treatment. The catheter tube is engineered with a smaller external diameter in the distal portion compared to the proximal portion, optimizing its functionality.
Career Highlights
Throughout his career, Michael Büchert has worked with several companies, including Acandis GmbH and Adceris GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to innovative medical solutions. His work has been instrumental in advancing catheter technology, particularly in the context of hypothermic treatments.
Collaborations
Büchert has collaborated with various professionals in the field, including Julia Wolfertz and Giorgio Cattaneo. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the development of medical technologies.
Conclusion
Michael Büchert's contributions to medical catheter technology exemplify the impact of innovation in healthcare. His patented designs and collaborative efforts continue to influence the field, paving the way for improved treatment options for patients.